Experts Urge Belgium to Reimburse New Alzheimer’s Treatments
Belgian medical experts are urging Riziv, the National Institute for Health and Disability Insurance, to reimburse new monoclonal antibody treatments for early-stage Alzheimer’s. These therapies target amyloid-beta plaques to slow ... Read More